13:22 30.09.2009, Nutritional formula linked to reduced CD 4 cell loss in untreated people From the ICAAC meeting in San Francisco
A complex nutritional formula may help slow CD 4 cell decline and reduce immune activation in people with HIV who have not yet started antiretroviral therapy, according to an international
13:21 30.09.2009, Dual maintenance therapy with atazanavir plus raltegravir sustains viral suppression presented at the ACAAC conference in San Francisco
A two-drug maintenance regimen using the protease inhibitor atazanavir (Reyataz) and the integrase inhibitor raltegravir was well tolerated and kept viral load suppressed, according to
13:20 30.09.2009, GS-9380 boosts atazanavir jsut as well as ritonavir From the ICAAC meeting in San Francisco Sept 28,2009
GS-9350, a new pharmacoenhancer being developed by Gilead sciences, equals ritonavir (Norvir) as a booster of blood levels of atazanavir.
13:18 30.09.2009, Tobacco, marijuana and alcohol may lower levels of some anti-HIV drugs from Inter science Conference on Anti microbial agents and Chemotherapy
Tobacco and marijuana may reduce levels of atazanavir (Reyataz) in the body, whilst tobacco and alcohol may lower efavirenz (Sustiva) levels in individuals who carry specific genetic variations
13:17 30.09.2009, Inflammation signals heart disease risk in people with HIV Journal of Clinical Infectious Disease
Markers of inflammation usually related to chronic viral infection and implicated in the long-term development of heart disease are likely to be higher in people with HIV than healthy
13:16 30.09.2009, Deportation of migrants with HIV often contravenes human rights treaties.
National governments should reconsider deportation policies for people living with HIV, Human Rights Watch said in a report. The organization called on governments, international agencies
13:14 30.09.2009, Reduced efavirenz dose safe and effective in patients with high blood levels of drug
Doses of evavirenz can be safely reduced in patients who have high blood concentration of the drug a group of investigators reported from Holland. Reducing the dose of the drug meant that
11:41 23.09.2009, Stem Cell Face Sculpting Newman MD LA Health September 2009
The field of medicine is entering a new era with the use of stem cell technology. This author a plastic surgeon uses fat from your own body, known as aulogous adult adipose derived
11:38 23.09.2009, Revolutionary Break through in Hair Growht Treatment. Trinity Med Clinic LA Health September 2009
One of the major sources of hair loss is poor scalp blood circulation. If hair does not get a constant and good supply of blood, lymph, oxygen and nutrients, it will shrink and
14:33 20.09.2009, Brain penetrating anti-HIV drugs HIV weekly September 16,2009
A large study in the US comprising 200 children found that children treated with anti-HIV drugs that penetrate into the central nervous system, reduced the risk of children dying, as well as
14:28 20.09.2009, Raltegravir approved for first-time use in Europe. AIDS Weekly September 16,2009
Raltegravir, the first integrase inhibitor approved for use, has taken an important step towards approval for use by people starting HIV treatment in Europe. Raltegravir stops HIV
12:17 16.09.2009, The Perilous success: what if the new HIV prevention methods work? From AIDS Weekly week of Sept.15,2009
Within a couple of years time, we may know if two crucial new HIV prevention approaches will work. If they do, what then? Who will pay for them, who will use them, and will their use have
11:38 14.09.2009, Ruling out Venous thromboembolism with Point-or Care D-Dimer testing Journal Watch
In a meta-analysis, sensitivity of four point-of-care D-dimer tests ranged from 85% to 96%. This is very encouraging to people who travel a lot and have their legs crossed. It means
11:37 14.09.2009, FDA Approves Blood Test to Guide Referrals for Pelvic Masses FDA
OVA-1, a blood test that measures five protein levels that change in the presence of ovarian cancer, has been approved as an adjunctive test in the evaluation of pelvic masses. The test
11:35 14.09.2009, HIV and treatment
It is now recommended that you should start HIV treatment when your CD4 cell count is around 350. This not only reduces the risk of developing HIV-related illnesses, but also reduces the
11:33 14.09.2009, Preventing and curing HIV
Scientists have recently identified two new antibodies that seem to neutralize a wide range of HIV types and block infection with the virus. This could be very useful in helping the
11:40 09.09.2009, Fewer Drugs, Same Outcome Simpler HIV regimens are effective.jAMA Aug.16,2009
Dr. Roy Gulick of Weil Medical College in New York City reports that 4 drugs he tested work no better than three drugs. Beginning in 2001 his research team issued the current standard
11:31 09.09.2009, MRSA Carriage from the Hospital to the Home
Nearly 20% of household contacts acquired MRSA during 1 year after patient discharge; none developed MRSA infections.
11:29 09.09.2009, Low Level Viremia Affects Immunity in Elite Controllers
Higher levels of detectable virus on an ultrasensitive assay correlated with stronger antibody responses but had no relation to HIV-specific T-cell response.
11:13 01.09.2009, Mediterranean Diet Improves Glycemic Control in Patients with Type # Diabetes. Annals of Internal Medicine August 2009
A Mediterranean style diet may be better than a low-fat diet for helping patients with type 2 diabetes, delay treatment with anihyperglycemic drugs,. Italian researches randomized some 200